Blog
9 February, 2022
Since yesterday, the new Clinical Trials Information System (CTIS) has been operational, which centralizes processes with the aim of speeding up these studies Our country starts […]
3 February, 2022
The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: www.actasanitaria.com With the entry […]
24 January, 2022
A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]
13 December, 2021
More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]
17 November, 2021
Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]
4 November, 2021
Source: www.immedicohospitalario.es The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]
21 June, 2021
Source: www.actasanitaria.com Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]
8 June, 2021
Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]
21 May, 2021
Via: www.consalud.es The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]
20 May, 2021
Via: www.immedicohospitalario.es Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]
10 May, 2021
Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can […]
6 May, 2021
In just two decades, the European Union has gone from leading global biomedical R&D to being the origin of only 23% of new drugs, while 47% […]
27 April, 2021
The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends […]
15 April, 2021
Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with […]
17 March, 2021
Pharmacological treatments, together with heart-healthy lifestyles, are the factors that contribute the most to improving the control of these pathologies The pharmaceutical industry has 600 investigational […]
11 March, 2021
A new study evaluates the availability, quality and reimbursement of these tests in the European Union It proposes short and long-term measures to move towards precision […]
4 March, 2021
The European Regulation on Orphan Medicines of the year 2000 has been the key in this research launch A quarter of the annual approvals of new […]
23 February, 2021
Medications and vaccines don’t come out of nowhere. They are not done in a rush and they are not due to commercial gimmicks. They are the […]
5 February, 2021
Source: https: www.diariofarma.com Cancer continues to be one of the main fronts of the fight for drug research. On the occasion of tomorrow’s World Cancer Day […]
26 January, 2021
An American study indicates that these cells can fight breast, colon and lung cancer Source: www.redaccionmedica.com A new study, led by researchers at UT Southwestern (UTSW) […]
14 December, 2020
Source: www.lne.es New drugs are responsible for 73% of the prolongation of life expectancy in developed countries and have managed to solve more and more diseases. […]
9 December, 2020
Source: www.lavozdegalicia.es The sector has registered an investment in research and development of 1,211 million euros in 2019, 5.2% more than the previous year In these […]
30 November, 2020
Source: www.noticias.juridicas.com Royal Decree 957/2020, of November 3, establishes the conditions that must be met to proceed with the evaluation, performance and monitoring of observational studies […]
19 November, 2020
New meeting of the Farma-Biotech program, which brings start-ups and research groups into contact with national and international pharmaceutical companies to promote preclinical research and facilitate […]
9 November, 2020
Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy […]
6 November, 2020
So, in an exercise of transparency, anyone can have access to this data Carmen Montoto, Takeda Medical Director in Spain Source: www.redaccionmedica.com As part of its […]
23 October, 2020
In the workshop “Digital challenges in the management of clinical trials”, organized by Farmaindustria, its attendees have shown their commitment to digitization to help Spain consolidate […]
21 October, 2020
The objective of this meeting has been to present the latest advances in the area of Oncology with experts of national and international origin and to […]
20 October, 2020
Nine out of ten women diagnosed in Spain survive to 5 years The development of more precise, effective treatments with fewer side effects, together with the […]
5 October, 2020
Source: www.redaccionmedica.com María Blasco recalls that investment in science “is not even at the levels prior to 2010” Scientists gathered at the meeting ‘A new […]